Osteoporosis Awareness in Rheumatoid Arthritis Patients

Sponsor

Uskudar State Hospital (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT05740085

Collaborator

(none)

100

Enrollment

Location

Anticipated Duration (Months)

24.9

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Osteoporosis is a condition that describes compromised skeletal microarchitecture in general, with clinical signs of decreased bone mineral density. Rheumatoid arthritis patients are at increased risk for developing osteoporosis. It is crucial to identify whether rheumatoid arthritis patients know and know about this disease. This study investigates awareness and knowledge of osteoporosis in rheumatoid arthritis patients.

Condition or Disease	Intervention/Treatment	Phase
Osteoporosis Rheumatoid Arthritis	Other: Patient information form

Detailed Description

Osteoporosis is a common disease of bone loss. The reduced bone strength predisposes an increased risk for fractures in older individuals. It can affect people from different ethnicity. Many factors increase the risk of osteoporosis, including age, postmenopausal state, glucocorticoid use, low body weight, calcium, vitamin D, immobility, and chronic inflammation. Patients with rheumatoid arthritis are at high risk of developing osteoporosis due to chronic inflammation and the medications they use. Patients' knowledge and awareness about osteoporosis are essential for early detection, implementation of lifestyle changes, and treatment compliance. This study aimed to investigate osteoporosis awareness and knowledge about osteoporosis in patients with rheumatoid arthritis.

Study Design

Study Type:

Observational [Patient Registry]

Anticipated Enrollment :

100 participants

Observational Model:

Ecologic or Community

Time Perspective:

Prospective

Official Title:

Knowledge and Awareness of Osteoporosis in Rheumatoid Arthritis Patients

Anticipated Study Start Date :

Apr 30, 2023

Anticipated Primary Completion Date :

Jul 30, 2023

Anticipated Study Completion Date :

Aug 30, 2023

Arms and Interventions

Arm	Intervention/Treatment
Rheumatoid Arthritis Patients Patients that are diagnosed with rheumatoid arthritis	Other: Patient information form Patients will be asked to fill out a patient information form and an osteoporosis awareness form

Arm

Intervention/Treatment

Rheumatoid Arthritis Patients

Patients that are diagnosed with rheumatoid arthritis

Other: Patient information form

Patients will be asked to fill out a patient information form and an osteoporosis awareness form

Outcome Measures

Primary Outcome Measures

Level of knowledge in osteoporosis [1 day]
Level of knowledge in osteoporosis will be assessed with revised osteoporosis knowledge test (OKT). The Revised OKT (2012) is a comprehensive instrument reflecting current research and assesses osteoporosis knowledge of adults. Responses offered to participants are multiple choice (e.g., for risk items: more likely, less likely, neutral, don't know), there is only one correct answer for each item. Responses are dichotomously recoded as correct or incorrect. In a U.S. sample of adults, the measure demonstrated internal consistency, very good stability, and content validity. Point-biserial correlations supported the measure's validity.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 90 Years

Sexes Eligible for Study:

All

Inclusion Criteria:

Clinical diagnosis of rheumatoid arthritis
Must be between the ages of 18 and 90
Must give consent to participate in the study

Exclusion Criteria:

• Not giving consent

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Üsküdar State Hospital	Istanbul	Üsküdar	Turkey

Sponsors and Collaborators

Uskudar State Hospital

Investigators

Study Chair: Mustafa H Temel, M.D., Uskudar State Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Mustafa Hüseyin Temel, Principal Investigator, Uskudar State Hospital

ClinicalTrials.gov Identifier:

NCT05740085

Other Study ID Numbers:

OPRA1

First Posted:

Feb 22, 2023

Last Update Posted:

Feb 22, 2023

Last Verified:

Feb 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Arthritis

Arthritis, Rheumatoid

Osteoporosis

Study Results

No Results Posted as of Feb 22, 2023